TL;DR
- •Lithium is the gold-standard mood stabilizer with decades of evidence for preventing both manic and depressive episodes, plus the strongest antisuicide data of any psychiatric medication. Lamotrigine is FDA-approved for bipolar maintenance and is particularly effective at preventing depressive episodes.
- •Lithium has stronger evidence for preventing manic/mixed episodes. Lamotrigine has stronger evidence for preventing depressive episodes specifically — the two have complementary phase-specific profiles.
- •Lithium has a tight therapeutic window (target serum level 0.6-1.0 mEq/L for maintenance) and requires regular blood-level, kidney, and thyroid monitoring. Lamotrigine doesn't require routine blood-level monitoring.
- •Lamotrigine's most serious risk is Stevens-Johnson Syndrome / TEN (life-threatening skin reaction), which is why titration is slow (typically 25mg/day for 2 weeks, then very slow increases). The risk drops substantially after the first ~12 weeks of stable dosing.
- •Lithium's main long-term concerns are renal toxicity (chronic kidney function decline with years of use) and thyroid dysfunction — requiring lifelong monitoring even when stable.
- •Many bipolar patients end up on both — lithium for manic-episode prevention plus lamotrigine for depressive-episode prevention. The combination is well-tolerated.
- •For bipolar depression that breaks through mood stabilizers, ketamine has emerging evidence — but bipolar use requires extra caution and physician screening for mania risk.
Side by side
Lamotrigine
Lamotrigine (brand: Lamictal)
Anticonvulsant / mood stabilizer
What it treats
Bipolar maintenance (especially depressive-episode prevention), Epilepsy (partial and generalized seizures), Off-label: unipolar depression augmentation
Mechanism
Inhibits voltage-gated sodium channels and reduces glutamate release. The exact mood-stabilizing mechanism is incompletely understood but appears to favor depressive-episode prevention more than manic.
Strengths
- •Strong evidence for preventing bipolar depressive episodes
- •No routine blood-level monitoring required
- •Weight-neutral (no weight gain)
- •No sexual dysfunction
- •No cognitive blunting typical of some mood stabilizers
Limitations
- •Stevens-Johnson Syndrome risk requires slow 6-8 week titration to therapeutic dose
- •Less effective than lithium at preventing manic episodes
- •Drug interactions affect dosing (oral contraceptives reduce lamotrigine levels; valproate increases them)
- •Slow onset of mood-stabilizing effect (weeks to months)
Lithium
Lithium carbonate
Mood stabilizer (alkali metal salt)
What it treats
Bipolar maintenance (manic-episode prevention), Acute mania, Augmentation of antidepressants in unipolar depression, Suicide-risk reduction in mood disorders
Mechanism
Affects multiple intracellular signaling pathways including inositol monophosphatase and GSK-3 inhibition. Decades of clinical use; the exact mood-stabilizing mechanism is still incompletely understood despite the extensive evidence base.
Strengths
- •Gold-standard mood stabilizer with decades of evidence
- •Strongest evidence for preventing manic episodes
- •Best antisuicide evidence of any psychiatric medication
- •Effective in acute mania and maintenance both
- •Augments antidepressants in treatment-resistant unipolar depression
Limitations
- •Tight therapeutic window (0.6-1.0 mEq/L maintenance) requires regular blood-level monitoring
- •Chronic kidney function decline with long-term use — renal monitoring required
- •Thyroid dysfunction with long-term use — TSH monitoring required
- •Tremor, polyuria, weight gain, GI side effects
- •Toxicity at supratherapeutic levels (dehydration, NSAID interactions, diuretic interactions)
Which one for your situation?
If:
Bipolar I patient with predominant manic episodes
Verdict:
Lithium — strongest manic-episode prevention evidence
If:
Bipolar II patient with predominant depressive episodes
Verdict:
Lamotrigine — strongest depressive-episode prevention evidence
If:
Active suicidal ideation in bipolar disorder
Verdict:
Lithium — strongest antisuicide evidence
If:
Pre-existing kidney disease or chronic NSAID use
Verdict:
Lamotrigine — avoids lithium's renal burden
If:
History of rash or drug hypersensitivity
Verdict:
Lithium — avoids lamotrigine's Stevens-Johnson risk (rash history substantially increases risk)
If:
Mixed bipolar presentation with both manic and depressive vulnerability
Verdict:
Combination (lithium + lamotrigine) is common and well-tolerated — complementary mechanisms cover both phases
Where ketamine fits
For bipolar depression breaking through mood-stabilizer treatment, ketamine has emerging evidence. Tovani screens carefully for bipolar history and coordinates with the patient's mood-stabilizer prescriber. Bipolar patients can respond to ketamine but require extra monitoring for mood-cycling and emergent hypomania.
Lamotrigine: weeks to months for full mood-stabilizing effect. Lithium: 1-2 weeks for acute mania, longer for full maintenance effect. Ketamine: hours for acute mood response — but bipolar use requires careful coordination with maintenance mood stabilizers.
5-minute screening · Reviewed by a board-certified physician · FL & NJ
Frequently asked
Is lithium still the gold standard for bipolar?
Yes — lithium retains gold-standard status for bipolar maintenance, especially for manic-episode prevention and antisuicide effect. No newer mood stabilizer has matched lithium's combined evidence base across these dimensions. The trade-offs (kidney/thyroid monitoring, tight therapeutic window) are real but well-managed in established protocols.
Why does lamotrigine take so long to start?
The slow titration (typically 25mg/day for 2 weeks, then small step-ups) reduces Stevens-Johnson Syndrome risk. Skin reactions are much more common when lamotrigine is started at higher doses or escalated quickly. After ~6-8 weeks at therapeutic dose, SJS risk drops substantially. The slow start is frustrating but evidence-based — faster titration is associated with much higher SJS rates.
Do I have to monitor lithium levels forever?
For chronic maintenance, yes — typical schedule is every 3-6 months for serum lithium level, kidney function (creatinine, eGFR), and thyroid function (TSH). The monitoring catches problems early enough to address them. Many patients tolerate lithium well for decades with adequate monitoring; problems usually emerge from missed monitoring rather than the medication itself.
Can I take lithium and lamotrigine together?
Yes — combining them is common and well-tolerated. Lithium covers manic-episode prevention; lamotrigine covers depressive-episode prevention. Many bipolar patients on monotherapy with either one end up on combination therapy because of incomplete coverage of both phases. The combination doesn't have major interaction concerns.
What about bipolar depression that breaks through?
Bipolar depression refractory to mood stabilizers is one of psychiatry's hardest problems. Standard escalation steps include atypical antipsychotics with bipolar depression indications (quetiapine, lurasidone, cariprazine), ECT, and increasingly ketamine. Ketamine for bipolar depression requires careful coordination — it can produce dramatic relief but carries some mood-cycling risk that requires close monitoring alongside maintenance mood stabilizers.
References
- Arnone D et al. 2025, Pharmaceuticals. Meta-analysis of lamotrigine efficacy in unipolar and bipolar depression — supports the depressive-episode prevention indication. PMID 41155702
- Fornaro M et al. 2026, Journal of Affective Disorders. Efficacy and safety of pharmacological interventions for maintenance treatment of bipolar disorder. PMID 41985753
- Macaron MM et al. 2026, Therapeutic Advances in Psychopharmacology. Systematic review and meta-analysis of lithium vs other agents on kidney function over long-term treatment. PMID 41727809
- Saxena A et al. 2026, Clinical Toxicology. Systematic review of lamotrigine-induced Stevens-Johnson syndrome case reports — characterizes risk profile and timing. PMID 41843406